Innovent Biologics
SEHK:1801
HK$ 85,50
+ HK$6,10 (7,68%)
85,50 HK$
+HK$6,10 (7,68%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$0,52
Earnings Per Share
HK$8,48
Revenue Per Share
76,42%
Gross Margin %
HK$137,77 B
Market Cap
HK$2,21 B
Long-Term Debt
Earnings Per Share
HK$0,52
Revenue Per Share
HK$8,48
Gross Margin %
76,42%
Market Cap
HK$137,77 B
Long-Term Debt
HK$2,21 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017
EPS Earnings Per Share HK$0,52 HK$-0,06 HK$-0,66 HK$-1,65 HK$-1,54 HK$-0,44 HK$-1,33 HK$-1,25 HK$-5,52
Earnings Earnings HK$890,30M HK$-98,29M HK$-1,07B HK$-2,53B HK$-2,25B HK$-617,22M HK$-1,68B HK$-1,44B HK$-661,79M
RPS Revenue Per Share HK$8,48 HK$6,12 HK$3,83 HK$2,97 HK$2,92 HK$2,74 HK$0,83 HK$0,01 HK$0,15
Revenue Revenue HK$14,51B HK$10,03B HK$6,21B HK$4,56B HK$4,27B HK$3,84B HK$1,05B HK$9,48M HK$18,54M
OCF Operating Cash Flow HK$3,30B HK$1,37B HK$147,81M HK$-1,92B HK$-2,02B HK$-307,69M HK$-1,66B HK$-1,02B HK$0,00M
FCF Free Cash Flow HK$710,91M HK$341,98M HK$-1,21B HK$-2,82B HK$-3,09B HK$-796,71M HK$-2,03B HK$-1,33B HK$0,00M
OM Operating Margin 5,38% -2,94% -25,20% -68,54% -63,31% -14,50% -173,71% 0,00% 0,00%
GM % Gross Margin % 76,42% 74,40% 70,89% 69,67% 71,32% 79,92% 40,37% 100,00% 100,00%
FCFS Free Cash Flow Per Share HK$0,00 HK$-0,23 HK$-0,79 HK$-2,20 HK$-2,66 HK$-0,61 HK$-1,72 HK$-3,96 HK$-6,18
LT Debt Long-Term Debt HK$2,21B HK$2,57B HK$2,33B HK$2,22B HK$2,02B HK$925,18M HK$808,00M HK$782,00M HK$3,56B
Sha. Stocks 1.712,12M 1.638,15M 1.621,83M 1.534,41M 1.462,11M 1.402,78M 1.262,56M 1.153,6M 119,89M
×